77. Growth hormone secreting pituitary adenoma Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 351 / Drugs : 241 - (DrugBank : 28) / Drug target genes : 26 - Drug target pathways : 87
Growth hormone secreting pituitary adenoma and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 77 | Growth hormone secreting pituitary adenoma | - |
| 81 | Congenital adrenal hyperplasia | 2.000 |
| 206 | Fragile X syndrome | 2.000 |
| 225 | Congenital nephrogenic diabetes insipidus | 2.000 |
| 233 | Wolfram syndrome | 2.000 |
| 301 | Macular dystrophy | 2.000 |
| 13 | Multiple sclerosis | 2.000 |
| 6 | Parkinson disease | 2.000 |
| 299 | Cystic fibrosis | 2.000 |
| 2 | Amyotrophic lateral sclerosis | 2.000 |
| 75 | Cushing disease | 2.000 |
| 46 | Malignant rheumatoid arthritis | 2.000 |
| 49 | Systemic lupus erythematosus | 2.000 |
| 60 | Aplastic anemia | 2.000 |
| 65 | Primary immunodeficiency | 2.000 |
| 67 | Polycystic kidney disease | 2.000 |
| 86 | Pulmonary arterial hypertension | 2.000 |
| 127 | Frontotemporal lobar degeneration | 2.000 |
| 158 | Tuberous sclerosis | 2.000 |
| 285 | Fanconi anemia | 2.000 |
| 8 | Huntington disease | 2.000 |
| 113 | Muscular dystrophy | 2.000 |
| 265 | Lipodystrophy | 2.000 |
| 97 | Ulcerative colitis | 2.000 |